Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study.

Front Oncol · 2022 · PMC9459168 · PMID 36091103

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Notably, a differed HR status was validated as the prognostic significant factor in breast cancer bone metastasis, and the results may be significant for risk stratification in breast cancer bone metastasis and guide tailored treatment.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.